Retina International is delighted to congratulate Dr. Jacque Duncan, MD, FARVO, on being named the 2025 recipient of the Oberdorfer Award in Low Vision Research by the ARVO Foundation. This prestigious award recognizes Dr. Duncan’s pioneering work in advancing our understanding of inherited retinal degenerations (IRDs) and her dedication to developing high-resolution imaging techniques that provide new insights into low vision.
As Co-Chair of Retina International’s Scientific and Medical Advisory Board (SMAB), Dr. Duncan has been instrumental in guiding global efforts to improve the diagnosis, monitoring, and treatment of retinal diseases. Her research, which uses adaptive optics to study vision cells in IRD patients, is driving critical advancements in the field and bringing new hope to individuals living with vision loss.
Dr. Duncan’s leadership and expertise extend beyond the lab – she has been a key advocate for patient-centered research and a champion of collaborative approaches that bring together clinicians, scientists, and patient communities to advance innovation. Her commitment to evidence-based progress aligns perfectly with Retina International’s mission to promote scientific excellence, education, and advocacy for those affected by retinal diseases worldwide.
We look forward to Dr. Duncan’s lecture at the 2025 ARVO Annual Meeting in Salt Lake City, Utah, where she will share insights from her groundbreaking work. This award is a well-deserved recognition of her contributions, and we are incredibly proud to have her as part of our leadership at Retina International.
Congratulations, Dr. Duncan, from all at Retina International.
